BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 31364021)

  • 1. Defining new biomarkers for overcoming therapeutical resistance in cervical cancer using lncRNA.
    Aswathy R; Sumathi S
    Mol Biol Rep; 2023 Dec; 50(12):10445-10460. PubMed ID: 37878205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA CCHE1 modulates LDHA-mediated glycolysis and confers chemoresistance to melanoma cells.
    Ding Z; Yang J; Wu B; Wu Y; Guo F
    Cancer Metab; 2023 Jul; 11(1):10. PubMed ID: 37480145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and clinical diagnostic value of CCHE1 in breast cancer.
    Zhao F; Zhou W; Xin R; Miao X
    Mutagenesis; 2024 Mar; 39(2):141-145. PubMed ID: 38150355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNA polymorphisms in gynecological cancers.
    Abdi E; Latifi-Navid S; Panahi A
    Per Med; 2024 Jan; 21(1):59-68. PubMed ID: 38095072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retraction notice to "Long non-coding RNA HULC interacts with miR-613 to regulate colon cancer growth and metastasis through targeting RTKN" [Biomed. Pharmacother. 109 (2019) 2035-2042].
    Dong Y; Wei MH; Lu JG; Bi CY
    Biomed Pharmacother; 2023 Nov; 167():115370. PubMed ID: 37802725
    [No Abstract]   [Full Text] [Related]  

  • 6. SOX21-AS1 Augmented Cervical Cancer Growth by Triggering FZD3 to Activate the Wnt/β-Catenin Signaling Pathway.
    Zhi Y; Du P; Li Y; Liu H; Jiang T; Zhao X; Li X
    Biochem Genet; 2024 Mar; ():. PubMed ID: 38512584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression Level of lncRNA CYTOR in Iranian Cervical Cancer Patients.
    Rajabi A; Dastmalchi N; Shokri N; Tayefeh-Gholami S; Yaghoubi SM; Safaralizadeh R
    Rep Biochem Mol Biol; 2023 Apr; 12(1):120-126. PubMed ID: 37724154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The IncRNA SCIRT Promotes the Proliferative, Migratory, and Invasive Properties of Cervical Cancer Cells by Upregulating MMP-2/-9.
    Guan C; Wang B; Dong Q
    J Oncol; 2022; 2022():3448224. PubMed ID: 35979035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum Levels of lncRNA CCHE1 and TCF21 in Patients with Coronary Artery Disease and Their Clinical Significances.
    Liu M; Zhang Y; Cao X; Wang X
    Dis Markers; 2021; 2021():8526144. PubMed ID: 34970358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA HULC contributes to paclitaxel resistance in ovarian cancer via miR-137/ITGB8 axis.
    Huang B; Wei M; Hong L
    Open Life Sci; 2021; 16(1):667-681. PubMed ID: 34250246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA PVT1 promotes cervical cancer progression by sponging miR-503 to upregulate ARL2 expression.
    Liu W; Yao D; Huang B
    Open Life Sci; 2021; 16(1):1-13. PubMed ID: 33817293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Long Noncoding RNAs in Human Papillomavirus-associated Pathogenesis.
    Sharma S; Munger K
    Pathogens; 2020 Apr; 9(4):. PubMed ID: 32326624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNA
    Guo Q; Zhang Q; Lu L; Xu Y
    Cell Cycle; 2020 May; 19(10):1222-1235. PubMed ID: 32264732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical important dysregulation of long non-coding RNA CCHE1 and HULC in carcinogenesis of cervical cancer.
    Naghashi N; Ghorbian S
    Mol Biol Rep; 2019 Oct; 46(5):5419-5424. PubMed ID: 31364021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA CCHE1 promotes cervical cancer cell proliferation via upregulating PCNA.
    Yang M; Zhai X; Xia B; Wang Y; Lou G
    Tumour Biol; 2015 Sep; 36(10):7615-22. PubMed ID: 25921283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of lncRNA HULC in cervical cancer and its correlation with tumor progression and patient survival.
    Wang YF; Zhang S; Li XQ; Wang Y
    Eur Rev Med Pharmacol Sci; 2016 Oct; 20(19):3987-3991. PubMed ID: 27775802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA CCHE1 overexpression predicts a poor prognosis for cervical cancer.
    Chen Y; Wang CX; Sun XX; Wang C; Liu TF; Wang DJ
    Eur Rev Med Pharmacol Sci; 2017 Feb; 21(3):479-483. PubMed ID: 28239824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cervical carcinoma high expressed 1 (CCHE1): An oncogenic lncRNA in diverse neoplasms.
    Ghafouri-Fard S; Azimi T; Taheri M
    Biomed Pharmacother; 2021 Oct; 142():112003. PubMed ID: 34385101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNAs on the stage of cervical cancer (Review).
    Dong J; Su M; Chang W; Zhang K; Wu S; Xu T
    Oncol Rep; 2017 Oct; 38(4):1923-1931. PubMed ID: 28849103
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.